Recently, the Recombinant Five-antigen Staphylococcus Aureus Vaccine (rFSAV), a Class 1.1 New Drug co-developed by Chengdu Olymvax Biopharmaceuticals Inc.
Feb 18th 2025, Olymvax and Griffith University of Australia held a signing ceremony in Chengdu for their collaboration on the GAS project and contract manufacturing of GAS vaccine.
On May 8, 2022, the “OLYMVAX Cup” the 8th CMC College Student’s “Internet +” Innovation and Entrepreneurship Competition, jointly organized by Chengdu Olymvax Biopharmaceuticals Inc.
On the morning of March 16, 2022, Ms. Adelle Neary, Consul General of Australian Consulate General in Chengdu, and her delegation visited OLYMVAX and discussed the future cooperation between the two parties.
On March 14, 2022, the first batch of nearly 70,000 doses of Tetanus Vaccine, Adsorbed exported by Chengdu Olymvax Biopharmaceuticals Inc. was shipped to Pakistan.
Recently, the results of the “High-Integrity Enterprises” Selection and Publicity Campaign in Sichuan Province were announced, which was jointly organized by 25 departments such as Sichuan Provincial Development and Reform Commission, Cyberspace Administration Office of Sichuan Provincial Party Committee, and State-owned Assets Supervision and Administration Commission of Sichuan Province. Chengdu Olymvax Biopharmaceuticals Inc.
In the afternoon of August 25, 2021, Wang Yihong, Deputy Director of the NPC Standing Committee of Sichuan Province and Secretary General of the CPC Committee of Sichuan Province, and his delegation conducted an in-depth investigation on some listed and possibly listed pharmaceutical enterprises in Chengdu. Chengdu Olymvax Biopharmaceuticals Inc.